We are the leading non-profit patient advocacy organization, dedicated to
improving the lives of children, adults and families affected by SYNGAP1
"Never doubt that a small group of thoughtful, committed citizens can change the world; indeed, it's the only thing that ever has."
~ Margaret Mead
We come together, from diverse backgrounds, levels of experience and skill sets.
Together, we are accomplishing strategic goals and setting new goals.
Together, we are accelerating the creation of new research pathways to improve the lives of patients and families affected by SYNGAP1.
Our Advisory Board is comprised of a, diverse group of talented individuals, committed to supporting BTG's mission and vision.
Each member provides invaluable input and assistance with BTG programs and initiatives that benefit the SYNGAP1 community.
Our Medical/Scientific Advisory Board is comprised of talented and dedicated SYNGAP1 clinical and research experts. They inspire us with their deep commitment to SYNGAP1 patient-centered clinical healthcare and research. Their guidance, has been and continues to be, an essential component, driving who we are as an organization.
The Medical/Scientifc Advisory Board supports BTG's mission and vision through active engagement with our programs and initiatives, SYNGAP1 patients and families and other SYNGAP1 community stakeholders.
They support expansion of SYNGAP1 collaborative research efforts and provide encouragement to young neurscience investigators.